Anocca AB Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Anocca provides services like biotechnology, immunotherapeutics, drug discovery, drug development, and immunology services. The company does precise and efficient analysis of T-cell biology, which is required to deliver a variety of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas, including cancer, assisting the life sciences sector in developing a variety of therapies and vaccination strategies. Anocca was established on October 23, 2014 by Re

Repeat Founder
Company Highlights
Year Founded

2014

icon-altEmployees

112

Location (HQ)

SWE

Since Last Funding

1 year 5 months

Monthly Website Visitors

6.4K

icon-altTotal Investment Amt

$100M

Last Funding Round

Series Unknown

icon-altMoM Headcount Growth

2.75%

icon-altYoY Headcount Growth

19.13%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Biotechnology Research

Therapeutics